JAKARTA/SHANGHAI -- Indonesia's drug regulator on Friday announced it had authorized the emergency use of China's AWcorna COVID-19 vaccine, becoming the first known country to approve a Chinese mRNA jab.
Penny Lukito, head of the Food and Drug Monitoring Agency, known as BPOM, said studies had shown that AWcorna's overall efficacy against the coronavirus reached 83.58% -- and 71.17% against the highly infectious omicron variant.
